Inve India ▾

Fortis Healthcare share price & results

Fortis Healthcare Limited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Runs a 36-hospital, ~6,100-bed network across 12 states plus Agilus, its diagnostics chain of 400+ labs.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue489 ₹ crore+12.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin21.0 %+1.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit48.0 ₹ crore−7.7% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity11.34 %+1.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin7.37 %−0.2 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)17.50 %+4.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

6 of 7 judged targets kept · 15 open · verdicts reflect calls analysed to Q1 FY27.

Fortis Healthcare Limited management guidance track record on Inve: 22 targets tracked across analysed earnings calls (6 achieved, 1 missed, 15 open).

TargetOriginal wordingSaidLatest callVerdict
Legal & Legacy Costsreduction from next year onwards
Call transcript, Q4 FY25 · 21 May 2025		Q4 FY25Q1 FY27:Legal costs related to Delhi High Court hearings were cited as a factor impacting profitability, indicating costs have not reduced.
Call transcript, Q1 FY27 · 7 Aug 2026		Missed
FMRI Bed Operationalizationcommission it by March end (Q4 FY26)
Call transcript, Q2 FY26 · 12 Nov 2025		Q2 FY26Q1 FY27:Work completed, but occupancy certificate is still pending. Expected 'any time, maybe this month itself' (August 2026).
Call transcript, Q1 FY27 · 7 Aug 2026		Delayed
Hospital Margin Expansion2% growth in the forthcoming years
Call transcript, Q4 FY25 · 21 May 2025		Q4 FY25Q4 FY26:FY26 actual reported at 22.2% vs 20.5% in FY25, a 1.7% improvement.
Call transcript, Q4 FY26 · 25 May 2026		Achieved

Source: Inve Guidance Tracker for Fortis Healthcare Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Fortis Healthcare Limited's 22 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 19 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹736.5 +0.24% · +₹1.8

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −29.0% 1Y

₹0.7k₹0.8k₹0.9k₹1.0kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 12 Nov 2025Q3 FY26 — 16 Feb 2026Q4 FY26 — 25 May 2026Q1 FY27 — 7 Aug 2026

1Y: ₹1,037.3 on 24 Oct 2025 → ₹736.5. High ₹1,057 (28 Oct 2025), low ₹712.9 (23 Oct 2026).

Previous close
₹734.7
Market cap
₹55.7k Cr
52-week range
₹712.9 – ₹1,057
One year
−30.03%
Price to earnings (TTM to Jun 2026)
52.25×
Return on equity (TTM to Jun 2026)
11.34%

Overview

Symbol
NSE:FORTIS
Exchange
NSE
Currency
INR

What Fortis Healthcare Limited does

Based on the company's own presentations, annual report and earnings calls.

Fortis Healthcare is an integrated healthcare delivery provider operating hospitals, day-care specialty facilities and, through majority-owned Agilus Diagnostics, a pathology and diagnostics chain. The hospital business earns from inpatient and outpatient care across specialties such as Cardiac Sciences, Oncology, Orthopedics, Neurosciences, Gastroenterology and Renal Sciences, treating domestic cash, TPA/insurance, government-scheme and international patients. Some hospitals are owned and operated directly while others are run under operations-and-management (O&M) or long-term lease arrangements with third-party owners. Agilus earns from diagnostic testing performed through its own labs and a wider network of customer touch points (collection centres) that feed samples into those labs.

Segments

  • Hospital Business
  • Diagnostics Business (Agilus)
Healthcare facilities
36 (including JVs and O&M facilities) across 12 states
Operational beds
~6,100 (including ~1,200 O&M beds)
Doctors on network
~7,900
Nurses (including trainees)
~9,300
NABH accredited/certified facilities
34
JCI accredited facilities
4
Founded 1996Headquarters Gurugram, Haryana, IndiaEmployees 28,000 (FY26 (as of March 31, 20) Company website

How the price took the results

close before → close after

Q1 FY27
+3.8%
7 Aug
Q4 FY26
+1.0%
25 May
Q3 FY26
−0.1%
16 Feb
Q2 FY26
−1.8%
12 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Fortis Healthcare Limited

Free account: one company. Everything above stays public.

Write why you follow Fortis Healthcare Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Fortis Healthcare Limited

Guides on how to read this kind of business and the numbers that matter.